Understanding the Net Asset Value of Alliance Trust PLC
Understanding Alliance Trust PLC's Net Asset Value
Alliance Trust PLC, a well-regarded investment company, has recently published its net asset values (NAV) for ordinary shares, showcasing their performance and market position. As of the close of business on a recent Thursday, the Company reported key figures that investors should note.
Recent NAV Performance
The Company’s NAV is an essential metric as it provides insights into the value of its assets. For the recent reporting period, the NAV per ordinary share valued on a bid price basis was detailed comprehensively:
Without Income Calculations
- Excluding income, the NAV stood at 1260.4p.
With Income Calculations
- Including income, the NAV slightly adjusted to 1260.1p.
These values are pivotal as they highlight the Company's financial health and market standing.
Debt Valuation Impact
Analyzing the debt at fair value provides another layer of understanding for investors. In this context, the NAV figures were:
Debt Valued at Fair
- Excluding income, 1266.1p.
- Including income, 1265.8p.
The changes in these figures reflect the overall financial dynamics that Alliance Trust PLC is navigating, especially in a fluctuating market.
Understanding the Implications
The publication of NAV figures not only informs current investors but also attracts potential investors by demonstrating transparency and economic viability. The decreasing NAV numbers could indicate challenges in the market; however, they could also present an attractive entry point for investors looking for opportunities.
Upcoming Dividend Payment
Moreover, it's noteworthy that a dividend of 6.62p is on the horizon, scheduled for payment on a specific date. This dividend has been deducted from the income figures mentioned earlier, following the ex-dividend date. Such dividends underline the importance of cash flows to shareholders, and they ensure that investors remain engaged with the Company's financial strategies.
For Further Assistance
Should investors wish to delve deeper into the financials of Alliance Trust PLC, they can reach out to:
Contact Information
Juniper Partners Limited
Tel. +44 (0)131 378 0500
Frequently Asked Questions
What is the NAV for Alliance Trust PLC?
The latest NAV per ordinary share was reported as 1260.4p excluding income, and 1260.1p including income.
Why is NAV important for investors?
NAV helps investors assess the value of their shares relative to the underlying assets, critical for making informed investment decisions.
What influences changes in NAV?
Market conditions, asset valuations, and management strategies significantly influence the NAV of an investment trust like Alliance Trust PLC.
When is the upcoming dividend payment?
The upcoming dividend of 6.62p is set to be paid on a specified date after the ex-dividend date.
How can I contact Alliance Trust PLC for more information?
Investors can reach out to Juniper Partners Limited via telephone at +44 (0)131 378 0500 for any inquiries regarding investments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Impact of Upcoming Presidential Election on Textile Retail Sector
- Exploring Unique News Stories Beyond the Ordinary
- Understanding the Ripple Effects of Tariffs on Inflation
- Impact of Recent Fed Rate Movements on Global Central Banks
- Exploring the Resurgence of Nuclear Energy Investments
- Strategies for Strengthening Your Investment Portfolio Now
- Strategic Moves for Investors as Fed Eases Monetary Policies
- Weekly Stock Picks: Highlights from the Market's Movers
- Unlocking Potential: The Influence of Digital Media on Companies
- Apple Harbors Ambivalence on OpenAI While Nvidia and Microsoft Engage
Recent Articles
- Ryde Group Ltd Strengthens Position Amid Share Price Fluctuations
- Pfizer and BioNTech's New COVID-19 Vaccine Now in EU Approval
- Agnico Eagle Enhances Detour Lake Mine with New Technical Report
- Hummingbird's LogicLoop Acquisition Transforms Data Automation Strategy
- Fidelis Care and Centene Foundation Empower Youth Mental Health
- o9's ESG Impact Report Highlights Strong Commitment to Sustainability
- Privacera Honored as AI Implementation Leader for 2024
- Adtran Unveils Coherent 100ZR and FSP 3000 at ECOC 2024
- Hawkins Way Capital Expands Student Housing with New Acquisition
- MicroStrategy's Successful Convertible Notes Offering Insights
- DEWALT Invests $4 Million in Future Trades Professionals
- Marinus Pharmaceuticals Showcases ZTALMY® Progress Ahead of Launch
- Cross Timbers Royalty Trust Announces September Distributions
- Hugoton Royalty Trust Announces No Cash Distribution for September
- GBS Leaders Embrace Productivity Improvements Amid Challenges
- YesWelder's Firstess DP200: A Game-Changer in Welding Solutions
- Exciting Updates from SolarBank on Financial Results and Call
- How a $1000 Bitcoin Investment Could Change Your Life
- Kangpu Biopharmaceuticals Successfully Completes KPG-818 Study
- Stryker Enhances Surgical Solutions with NICO Corporation Deal
- Bit Digital Strengthens HPC Division with New Leadership
- Mayer Brown Shines Bright at Global Derivatives Awards 2024
- Ameren Corporation Celebrates 10 Years of Disability Inclusion
- Flat Ads Shines Bright at Europe's Premier DMEXCO 2024 Event
- Actinium Pharmaceuticals Reveals Progress of Iomab-B Study
- Equinix's Key Participation in Upcoming Investor Conference
- Govee Launches Exciting New Curtain Lights Inspired by The Wild Robot
- Historic Ballot Access Wins for Green Party Candidates
- Arizona Voters Support Enhanced Higher Education Initiatives
- Dupixent Gains EU Approval for Pediatric Use in EoE Treatment
- Nokia Triumphs in Patent Conflict Against Amazon in Germany
- Global Engine Group Holding Limited Sets $8 Million IPO Price
- Berkshire Hathaway Reduces Bank of America Holdings Significantly
- Harbour Investment Partners Enhances Investment Strategies for Affluent Clients
- Introducing the Sensedge Go: The Next Generation Air Quality Monitor
- Predicted Growth of the Global Diagnostic Imaging Market
- Personalized Wealth Management Solutions from Harbour Partners
- CoinW Enhances Security Measures After Recent Industry Incident
- Nokia Launches Innovative Tool to Enhance Sustainability for Enterprises
- Dr. Carlo Papa Joins Board of Directors at Odysight.ai
- Explore the Advances in 3D Ceramic Manufacturing with SINTX
- Healthy Choice Wellness Launches New Pathway for Success
- Joint Venture Growth: Advancing 3D Printed Electronics Together
- Canacol Energy's 2024 Capital Plan and Drilling Progress Explained
- Urgently Divests The Floow to Sharpen Core Business Focus
- Dupixent Gains Momentum for Treating Pediatric Eosinophilic Esophagitis
- Dupixent® Gains Positive Recommendation for Young EoE Patients
- Hafnarfjörður's Positive Financial Results Surpass Expectations
- Mastering AI Prompts: A Guide to Stunning Visual Creations
- EU Committee Recommends Dupixent for Eosinophilic Esophagitis in Kids